跳至主要内容
临床试验/NCT00989911
NCT00989911已完成不适用

Endothelin Blockade in Patients With Single Ventricle Physiology

University of California, Los Angeles1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2010年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Pulmonary Blood Flow as Determined by MRI Velocity Encoding at 3-6 Months

研究概览

简要总结

Recent studies have shown beneficial effects of sildenafil in patients with single ventricle congenital heart disease. The purpose of this study is to determine whether Bosentan, a drug with similar effects, will have similar benefit in this patient population.

详细描述

Patients enrolled in the study will take Bosentan. Baseline and follow up measurements will be collected then analyzed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 12 years of age
  • Single ventricle congenital heart disease
  • Require cardiac magnetic resonance imaging (MRI) for clinical purposes.

排除标准

  • < 12 years of age
  • Pregnancy or women who may become pregnant (sexually active and unwilling to use birth control)
  • Patients taking cyclosporin or glyburide
  • Patients with baseline liver dysfunction (aspartate aminotransferase or alanine aminotransferase > 3 times upper limit of normal)
  • Contraindications to MRI (including pacemakers)
  • Use of Bosentan within one month prior to enrollment

研究组 & 干预措施

Bosentan

Experimental

Bosentan

干预措施: Bosentan (Drug)

结局指标

主要结局

Pulmonary Blood Flow as Determined by MRI Velocity Encoding at 3-6 Months

时间窗: 3-6 months

Magnetic resonance imaging-derived aortic flow

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jamil Aboulhosn

Assistant Professor of Medicine

University of California, Los Angeles

研究点 (1)

Loading locations...

相似试验